Korea-Serbia collaboration to establish vaccine manufacturing facilities

Xin Weisheng

Home > News > INDUSTRY NEWS >

08 Sep 2023
Korea-Serbia collaboration to establish vaccine manufacturing facilities

South Korea-based SK bioscience has announced that Ana Brnabić, Prime Minister of the Republic of Serbia (Serbia) visited the SK bioscience headquarters and signed a Memorandum of Understanding (MoU) with the company to establish a strategic partnership in vaccine development and manufacturing between the two countries.


Along with the MoU, SK bioscience, and Frontier Biopharma agreed to sign a contract within the year for collaborating to establish vaccine manufacturing facilities in Serbia with support from the Serbian government.


According to the MoU, SK bioscience will utilise its own vaccine R&D, manufacturing, and commercialisation capabilities for strengthening the vaccine manufacturing environment to a global-certified level, transferring technologies and know-how for pandemic preparedness, commercialising products, training human resources, and supporting the vaccine R&D in Serbia. The newly established platform will supply Serbia and other European and emerging markets from a hub in Serbia.


The Serbian government will provide administrative support related to the project and cooperate for possible supply of drug products in Serbia. Frontier Biopharma will be in charge of overall operation of the project.


The demand for localisation of vaccines in Serbia where most medical devices and medicines are currently imported from Europe and the United States is growing significantly. According to the 'Status of Korea-Serbia Cooperation Areas' report recently released by the 'Korea Trade-Investment Promotion Agency (KOTRA),' Serbia is actively seeking international collaborations and investing in biopharmaceutical and medical industry.


(Source: BioSpectrum Asia)

  • wechat
Recent Posts
  • Radiopharma-Focused CDMO Nucleus Unveils Two New Plants, Looks to Create 100 Jobs
    22 Oct 2024
    Radiopharma-Focused CDMO Nucleus Unveils Two New Plants, Looks to Create 100 Jobs
    Find out more
  • Just – Evotec Biologics Opens Its First J.POD Facility in Europe
    20 Sep 2024
    Just – Evotec Biologics Opens Its First J.POD Facility in Europe
    Find out more
  • AI biotechs Exscientia and Recursion agree $688m merger
    12 Aug 2024
    AI biotechs Exscientia and Recursion agree $688m merger
    Find out more

WANT TO KNOW MORE ABOUT HOW OUR

SOLUTIONS CAN HELP YOU?

Cookies
Our site uses cookies. We’d also like to set optional cookies to give you the best experience and porvide you relevant advertising. You can choose to manage your preferences or accept all cookies. You can also read our Privacy Policy and Cookie Policy for more information.